|
|
|
 |
|
|
|
 
|
Troels Mygind Jensen
MSc, PhD student
Research area
Discovery of new proteins involved in the development of type 2 diabetes through the analysis of protein profiles in a population at high diabetes risk; assessment of the role of the identified proteins in driving the mechanisms that lead to diabetes onset.
| Education |
| 2006-08 |
MSc in Biology-Biotechnology
University of Copenhagen, Faculty of Life Sciences, Copenhagen (Denmark) |
| 2002-06 |
BSc in Biotechnology
University of Copenhagen, Faculty of Life Sciences, Copenhagen (Denmark) |
| Positions |
| 2010- |
Research Fellow
Epidemiology research group, Steno Diabetes Center, Gentofte (Denmark).
Diabetes epidemiology and proteomics. |
| 2009-10 |
Assistant Research Scientist
New York University School of Medicine, Department of Physiology and Neuroscience, New York, NY (USA).
Immunotherapy of Alzheimer’s disease. |
| 2007-08 |
Master’s Thesis research
New York University, Department of Biology, New York, NY (USA).
Viral cancer therapy. |
| 2006 |
Laboratory Trainee
Fudan University, School of Life Sciences, Shanghai (China).
Viral cancer therapy. |
| Membership |
| Member of the European Association for the Study of Diabetes (EASD) |
| Presentations/Abstracts |
| 2009. American Society for Virology 28th Annual Meeting, Vancouver, BC (Canada): Recombinant Vesicular Stomatitis Virus (VSVNYU); A Novel Highly Attenuated Oncolytic Agent. Abstract. |
2010. 45th Annual Meeting of the European Diabetes Epidemiology Group (EDEG), Porto Heli (Greece): The association of anthropometric measures and abdominal fat measured by ultrasound with insulin resistance and beta cell function in a general population.
Abstract and poster presentation. |
2010. 46th Annual Meeting of the European Association for the Study of Diabetes (EASD), Stockholm (Sweden): The association between soluble urokinase plasminogen activator receptor (suPAR) levels and incident diabetes is modified by body weight status in high-risk people with impaired glucose regulation.
Abstract and poster presentation. |
| Publications |
| James M. Miller, Sarah M. Bidula, Troels M. Jensen, Carol S. Reiss. Cytokine-modified VSV is highly attenuated for neural pathology, but is both highly immunogenic and oncolytic. Intl J of Interferon, Cytokine and Mediator Research 2009:1;15-32 |
| James M. Miller, Sarah M. Bidula, Troels M. Jensen, Carol S. Reiss. Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo. Intl J of Interferon, Cytokine and Mediator Research 2010:2;1-10 |
|
| |
|
|
| |
|
|
|
|
|
|
|
|
Steno
Contact
Sitemap
